Stella Pharma (TSE:4888) Other Current Payables: 円73.6 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4888 Stella Pharma Corp TSE:4888
75 GF Score
Price 円390.00
GF Value 円371.18
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Stella Pharma Other Current Payables?

Stella Pharma TSE:4888 75 Other Current Payables is 円73.6 Mil as of Mar. 2026. GuruFocus rates TSE:4888 with a GF Score™ of 75/100 and a GF Value™ of 円371.18 (Fairly Valued). The stock has 4 warning signs investors should review.

Stella Pharma's Other Current Payables for the quarter that ended in Mar. 2026 was 円73.6 Mil.

Stella Pharma's quarterly Other Current Payables increased from Sep. 2025 (円33.2 Mil) to Dec. 2025 (円158.6 Mil) but then declined from Dec. 2025 (円158.6 Mil) to Mar. 2026 (円73.6 Mil).

Stella Pharma's annual Other Current Payables declined from Mar. 2024 (円202.3 Mil) to Mar. 2025 (円183.4 Mil) and declined from Mar. 2025 (円183.4 Mil) to Mar. 2026 (円73.6 Mil).

Stella Pharma Other Current Payables Related Terms

Stella Pharma Other Current Payables Historical Data

* Premium members only.

The historical data trend for Stella Pharma's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stella Pharma Other Current Payables Chart

Stella Pharma Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Payables
Get a 7-Day Free Trial 64.21 196.06 202.34 183.44 73.57

Stella Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.47 33.16 158.64 73.57 0.00
TSE:4888
75GF Score
Stella Pharma Corp TSE:4888
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stella Pharma Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of 円73.6 Mil mean?
Stella Pharma (TSE:4888) has a Other Current Payables of 円73.6 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Stella Pharma and its competitors.
Is Stella Pharma's Other Current Payables too high?
Stella Pharma's current Other Current Payables is 円73.6 Mil. Overall, Stella Pharma has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Stella Pharma's Other Current Payables compare to VRTX and REGN?
Stella Pharma's Other Current Payables of 円73.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Stella Pharma and its competitors. Stella Pharma's current Other Current Payables is 円73.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stella Pharma stock overvalued right now?
Based on GuruFocus' analysis, Stella Pharma (TSE:4888) is currently considered Fairly Valued. The stock's GF Value™ is 円371.18, compared to a current price of 円390.00 — trading 5.1% above its estimated fair value. The current Other Current Payables is 円73.6 Mil. Stella Pharma's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Stella Pharma (TSE:4888), the current Other Current Payables is 円73.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stella Pharma (TSE:4888) Overvalued in 2026?

Based on GuruFocus' analysis, Stella Pharma stock appears to be overvalued. The current stock price of 円390.00 is trading 5.1% above its estimated GF Value™ of 円371.18. GuruFocus considers Stella Pharma to be Fairly Valued.

Key valuation signals for TSE:4888:

  • Other Current Payables: 円73.6 Mil
  • GF Value™: 円371.18 vs. price of 円390.00 (5.1% above fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the TSE:4888 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stella Pharma Business Description

Address 3-2-7 Korai-bashi, Chuo-ku, Osaka Prefecture, Osaka, JPN, 541-0043
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.
75GF Score

Get the complete analysis for TSE:4888

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円390.00
Price
円371.18
GF Value